Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Sells $141,982.04 in Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 5,197 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $27.32, for a total value of $141,982.04. Following the sale, the insider now owns 17,139,023 shares in the company, […]

Related Keywords

Canada ,China ,Alaska ,United States , ,Jpmorgan Chase Co ,Needham Company ,Securities Exchange Commission ,Vir Biotechnology Inc ,Commonwealth Equity Services ,Royal Bank ,Nasdaq ,China Universal Asset Management Co ,Endurance Cayman Ltd Svf ,Summerhaven Investment Management ,Goldman Sachs Group ,Vir Biotechnology Company Profile ,Alaska Department Of Revenue ,Vir Biotechnology ,Get Rating ,Ltd Svf ,Exchange Commission ,Biotechnology Trading Down ,Haven Investment Management ,Universal Asset Management ,Alaska Department ,Equity Services ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,